Cargando…

Genetically proxied impaired GIPR signaling and risk of 6 cancers

Preclinical and genetic studies suggest that impaired glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling worsens glycemic control. The relationship between GIPR signaling and the risk of cancers influenced by impaired glucose homeostasis is unclear. We examined the association of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Miranda, Gill, Dipender, Ahlqvist, Emma, Robinson, Tim, Mariosa, Daniela, Johansson, Mattias, Cortez Cardoso Penha, Ricardo, Dossus, Laure, Gunter, Marc J., Moreno, Victor, Davey Smith, George, Martin, Richard M., Yarmolinsky, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209536/ https://www.ncbi.nlm.nih.gov/pubmed/37250804 http://dx.doi.org/10.1016/j.isci.2023.106848

Ejemplares similares

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
por: Fang, Si, et al.
Publicado: (2023)

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Killion, Elizabeth A., et al.
Publicado: (2020)

Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant
por: Yammine, Lucie, et al.
Publicado: (2023)

Leverage of genetic variants proxying smoking intensity to explore the broad health consequences of smoking
por: Gill, Dipender
Publicado: (2020)

Gipr Is Essential for Adrenocortical Steroidogenesis; However, Corticosterone Deficiency Does Not Mediate the Favorable Metabolic Phenotype of Gipr(−/−) Mice
por: Bates, Holly E., et al.
Publicado: (2012)

Genetically proxied lean mass and risk of Alzheimer’s disease: mendelian randomisation study
por: Daghlas, Iyas, et al.
Publicado: (2023)

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
por: Samms, Ricardo J., et al.
Publicado: (2022)

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
por: Campbell, Jonathan E.
Publicado: (2020)

Genetic disruption of the Gipr in Apoe(−/−) mice promotes atherosclerosis
por: Pujadas, Gemma, et al.
Publicado: (2022)

Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
por: Larsson, Susanna C., et al.
Publicado: (2021)

Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes
por: Gill, Dipender, et al.
Publicado: (2020)

Reagents and models for detecting endogenous GLP1R and GIPR
por: Ast, Julia, et al.
Publicado: (2021)

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
por: Yarmolinsky, James, et al.
Publicado: (2023)

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
por: El, Kimberley, et al.
Publicado: (2023)

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis
por: Pujadas, Gemma, et al.
Publicado: (2020)

GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai
por: Zhang, Lizhi, et al.
Publicado: (2022)

Molecular basis of signal transduction mediated by the human GIPR splice variants
por: Zhao, Fenghui, et al.
Publicado: (2023)

The Link between Three Single Nucleotide Variants of the GIPR Gene and Metabolic Health
por: Michałowska, Joanna, et al.
Publicado: (2022)

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
por: Yang, Bin, et al.
Publicado: (2022)

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
por: Yuan, Shuai, et al.
Publicado: (2021)

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Basedz Therapies in Treating Metabolic Disorders
por: Samms, Ricardo J., et al.
Publicado: (2021)

Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice
por: Wang, Xin-shang, et al.
Publicado: (2022)

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

Molecular Characterization of Grass Carp GIPR and Effect of Nutrition States, Insulin, and Glucagon on Its Expression
por: Yang, Guokun, et al.
Publicado: (2022)

Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
por: Manchanda, Yusman, et al.
Publicado: (2023)

Resistin Knockout Mice Exhibit Impaired Adipocyte Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Expression
por: Kim, Su-Jin, et al.
Publicado: (2013)

The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas
por: Dalle Nogare, Mattia, et al.
Publicado: (2023)

Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus
por: Burgess, Stephen, et al.
Publicado: (2021)

Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis
por: Hazelwood, Emma, et al.
Publicado: (2022)

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
por: Zhang, Qian, et al.
Publicado: (2021)

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
por: Lu, Shu-Chen, et al.
Publicado: (2021)

Association of gastric inhibitory polypeptide receptor (GIPR) gene polymorphism with type 2 diabetes mellitus in iranian patients
por: Erfanian, Saiedeh, et al.
Publicado: (2023)

SAT062 Inhibition Of GIPR Expression Enhances Sulfonylurea-induced Insulin Secretion, And It Was Associated With Changes In ATP Contents
por: Ah Kim, Hyun, et al.
Publicado: (2023)

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
por: Yarmolinsky, James, et al.
Publicado: (2022)

Two cases of disseminated tuberculosis after negative screening before adalimumab treatment for immune-mediated inflammatory diseases
por: Cortez de Almeida, Rita Fernanda, et al.
Publicado: (2019)

Kidney Function and Risk of Renal Cell Carcinoma
por: Alcala, Karine, et al.
Publicado: (2023)

GIPR rs1800437 polymorphism: prevalence and possible associations with metabolic syndrome-related diseases in a Brazilian urban population
por: da Silva Mattos, Alexandro Marcio, et al.
Publicado: (2015)

“Placebo by Proxy” and “Nocebo by Proxy” in Children: A Review of Parents' Role in Treatment Outcomes
por: Czerniak, Efrat, et al.
Publicado: (2020)

Proxy
por: Kirschner, Emilie
Publicado: (2012)

Postnatal Development of Numbers and Mean Sizes of Pancreatic Islets and Beta-Cells in Healthy Mice and GIPR(dn) Transgenic Diabetic Mice
por: Herbach, Nadja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c3e25gp203110qaf1dk6jsbl3g